News Formal

Daiichi Sankyo Leads Japan Pharma Stocks Higher on Cancer Drug

  • 📰 YahooFinanceCA
  • ⏱ Reading Time:
  • 14 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 9%
  • Publisher: 63%

日本 ニュース ニュース

日本 最新ニュース,日本 見出し

(Bloomberg) -- Daiichi Sankyo Co. shares jumped by the most in a year after a drug it developed with AstraZeneca Plc showed favorable results in a trial for a common type of breast cancer.Most Read from BloombergChinese Gold Buying Is Driving a Paradigm Shift in BullionStocks Flash Recession Warning as Trouble Spreads to IndustrialsIndia-Canada Clash Should Be a Wakeup CallWells Fargo Preps for Wealth Battle After $1 Billion TurnaroundCorzine Plans to Shut Hedge Fund and Return Capital to Invest

Awkward Encounters: Pushing Limits of EmbarrassmentSome providers are dropping gender-affirming care for kids even in cases where it's legal

ST. LOUIS — As Republican-led states have rushed to ban gender-affirming for minors, some families with transgender children found a bit of solace: At least they lived in states that would allow those already receiving puberty blockers or hormone therapy to continue.

このニュースをすぐに読めるように要約しました。ニュースに興味がある場合は、ここで全文を読むことができます。 続きを読む:

 /  🏆 47. in JP
 

コメントありがとうございます。コメントは審査後に公開されます。

日本 最新ニュース, 日本 見出し

Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。

Daiichi Sankyo Leads Japan Pharma Stocks Higher on Cancer DrugDaiichi Sankyo Co. shares jumped by the most in a year after a drug it developed with AstraZeneca Plc showed favorable results in a trial for a common type of breast cancer.
ソース: BNNBloomberg - 🏆 83. / 50 続きを読む »